宏創控股(002379.SZ)一季度預盈919.37萬-1194.12萬元 同比扭虧為盈
格隆匯4月14日丨宏創控股(002379.SZ)公佈,預計2022年第一季度歸屬於上市公司股東的淨利潤919.37萬元–1194.12萬元,上年同期虧損3609.81萬元;扣除非經常性損益後的淨利潤381.48萬元–495.48萬元,上年同期虧損3804.28萬元。
報吿期內,國內外鋁價同比大幅上漲,鋁滬倫比值進一步回落,利好鋁產品出口,公司持續優化產品結構,進行全面成本管控,營業收入規模同比增長,產品毛利率同比提高,整體盈利能力有所提升,經營業績實現扭虧為盈。
報吿期內,非經常性損益對當期淨利潤的正向影響約618萬元,主要是公司子公司確認的再生鋁項目政府補助。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.